Search

Your search keyword '"Vijai, Joseph"' showing total 849 results

Search Constraints

Start Over You searched for: Author "Vijai, Joseph" Remove constraint Author: "Vijai, Joseph"
849 results on '"Vijai, Joseph"'

Search Results

1. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

2. Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors

3. Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

4. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

5. The context-specific role of germline pathogenicity in tumorigenesis

6. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

7. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

8. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

9. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

10. Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes

11. The association between genetically elevated polyunsaturated fatty acids and risk of cancerResearch in context

12. Clonal hematopoiesis is associated with risk of severe Covid-19

13. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

14. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

15. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

16. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry

17. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

18. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

19. A genome-wide association study of marginal zone lymphoma shows association to the HLA region.

20. Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition

21. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

22. Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

23. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

25. Discovery of common and rare genetic risk variants for colorectal cancer

27. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

28. Supplementary Figure from Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort

29. Supplementary Data from Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort

30. Data from Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort

31. Data from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer

32. Supplementary Figures 1 - 6, Tables 1 - 2 from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer

33. Figure S2 from NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects

34. Data from HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes

35. Supplementary Table S7 from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

36. Supplementary Tables 1-4 from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

37. Supplementary Tables S2-S5 from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

38. Data from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

39. Supplementary Data from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

40. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

41. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

42. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

43. The association between genetically elevated polyunsaturated fatty acids and risk of cancer

44. Supplementary Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

45. Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

46. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

47. Supplementary Table 1 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

48. Supplementary Table S1 from Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma

49. Supplementary Figure S1 from Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma

50. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Catalog

Books, media, physical & digital resources